Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Combinatorial development of nebulized mRNA delivery formulations for the lungs

Combinatorial development of nebulized mRNA delivery formulations for the lungs

Thumbnail Image
Download
Name

nihms-1949779.pdf

Description
Accepted version
Size

2.29 MB

Format

Adobe PDF

Checksum (MD5)

59c9f4f1fa3e5caeaece5450d7437fac

sword-2025-10-10T22:13:19.original.xml (130 B)
Original SWORD entry document
Author(s)
Jiang, Allen Y
•
Witten, Jacob
•
Raji, Idris O
•
Eweje, Feyisayo
•
MacIsaac, Corina
•
Meng, Sabrina
•
Oladimeji, Favour A
•
Hu, Yizong
•
Manan, Rajith S
•
Langer, Robert
more
Date Issued
November 20, 2023
Journal
Nature Nanotechnology
Publisher
Springer Science and Business Media LLC
Citation
Jiang, A.Y., Witten, J., Raji, I.O. et al. Combinatorial development of nebulized mRNA delivery formulations for the lungs. Nat. Nanotechnol. 19, 364–375 (2024).
Version
Author's final manuscript
Abstract
Inhaled delivery of mRNA has the potential to treat a wide variety of diseases. However, nebulized mRNA lipid nanoparticles (LNPs) face several unique challenges including stability during nebulization and penetration through both cellular and extracellular barriers. Here we develop a combinatorial approach addressing these barriers. First, we observe that LNP formulations can be stabilized to resist nebulization-induced aggregation by altering the nebulization buffer to increase the LNP charge during nebulization, and by the addition of a branched polymeric excipient. Next, we synthesize a combinatorial library of ionizable, degradable lipids using reductive amination, and evaluate their delivery potential using fully differentiated air–liquid interface cultured primary lung epithelial cells. The final combination of ionizable lipid, charge-stabilized formulation and stability-enhancing excipient yields a significant improvement in lung mRNA delivery over current state-of-the-art LNPs and polymeric nanoparticles.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Koch Institute for Integrative Cancer Research at MIT
Massachusetts Institute of Technology. Department of Biological Engineering
Harvard University--MIT Division of Health Sciences and Technology
Institute for Medical Engineering and Science
Terms of Use
Creative Commons Attribution-Noncommercial-ShareAlike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/163165
DOI of Published Version
https://doi.org/10.1038/s41565-023-01548-3
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.